Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma <it>in situ</it>

<p>Abstract</p> <p>Background</p> <p>Endocrine therapy is commonly recommended in the adjuvant setting for patients as treatment for ductal carcinoma <it>in situ </it>(DCIS). However, it is unknown whether a neoadjuvant (preoperative) anti-estrogen approach to DCIS results in any biological change....

Descripción completa

Detalles Bibliográficos

Autores principales:	Shim Veronica, Chin Koei, Swain Rebecca, Lessing Juan, Anderson Joseph, DeVries Sandy, Chen Yunn-Yi, Esserman Laura J, Waldman Frederic M, Hwang E Shelley
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2009-08-01
Colección:	BMC Cancer
Acceso en línea:	http://www.biomedcentral.com/1471-2407/9/285
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!